Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Hotez Bottazzi

Texas researchers Maria Elena Bottazzi and Peter Hotez led development of the Corbevax patent-free Covid-19 vaccine. (Photo: Texas Medical Center)

Texas Team Applauded for Giving What Big Pharma Refuses: A Patent-Free Vaccine to the World

"We're not trying to make money. We just want to see people get vaccinated."

Brett Wilkins

A small team of Texas researchers is being hailed for developing an unpatented Covid-19 vaccine to share with the world without personal profit, with some advocates asking, if they can do it, why can't Big Pharma?

"If we had even a fraction of the support that Moderna had, who knows, maybe the world would be vaccinated by now."

Dubbed "the World's Covid vaccine," the inoculation—formally called Corbevax—is an open-source alternative to Big Pharma's patent-protected vaccines. Instead of being produced for profit, this shot could ultimately be manufactured around the world and made cheaply available to all without governmental or private legal retribution.

Common Dreams reported this week that Corbevax—developed jointly by Texas Children's Hospital, Houston's Baylor College, and the Indian pharmaceutical company Biological E. Limited—was authorized for emergency use in India amid a surge in infections driven by the highly contagious Omicron variant. Texas Children's Hospital says the new vaccine is at least 90% effective against the SARS-CoV-2 virus, and 80% or more effective against its Delta variant.

"We're not trying to make money," Peter Hotez, who led the Texas Children's Hospital team, told The Washington Post. "We just want to see people get vaccinated."

According to the Post, "Biological E. has ambitious plans to produce more than one billion doses of the vaccine in 2022." And while Hotez and Maria Elena Bottazzi at Baylor won't personally profit from vaccine they were instrumental in developing, the Post reports Baylor will take a fee.

Hotez said the Hyderabad-based pharma firm has about 150 million Corbevax doses ready to distribute, with 300 million more doses pre-ordered by the Indian government. The company hopes to ramp up production to 100 million monthly doses in order to better serve a nation in which only around 40% of the population are fully vaccinated.

Peter Maybarduk, director of the consumer advocacy group Public Citizen, said Thursday that "Texas Children's Hospital's commitment to sharing technology is a challenge to the pharma giants and the false narrative that vaccine production and medical innovation thrive through secrecy and exclusivity."

"If Texas Children’s Hospital can do it," he asked, "why can't Pfizer and Moderna?"

The Post continued:

Unlike the vaccines of big-name manufacturers such as Pfizer-BioNTech and Moderna, the Texas Children's Hospital vaccine... is being shared patent-free... The ambition is to create a low-cost, open-source alternative to expensive and limited-supply mRNA vaccines for developing and under-vaccinated countries. And it won't stop at India: Hotez and Bottazzi are talking to other manufacturers around the world and have consulted with the World Health Organization to see how they can share the vaccine globally.

If everything goes to plan, manufacturers all around the world could produce their own versions of the Texas Children's Hospital vaccine, which uses older recombinant protein technology that many manufacturers already have experience with, rather than newer and potentially more complicated technology. Some advocates hope it could be a model for how vaccines should be developed and shared globally during a pandemic.

"This vaccine can be made locally all over the world, and we've now technology-transferred our Texas Children's vaccine to producers in India, Indonesia, Bangladesh, [and] Botswana," Hotez tweeted Tuesday. "Our Texas Children's Center does not plan to make money on this, it's a gift to the world."

While Big Pharma corporations took billions of dollars in public funding to help develop vaccines from which they then reaped enormous profits while often charging exorbitant prices, Hotez and Battazzi created Corbevax with $7 million, mostly from private investors. One of these, Austin vodka distiller Tito's, contributed $1 million to the effort.

"If we had even a fraction of the support that Moderna had, who knows, maybe the world would be vaccinated by now," Hotez told the Post. "We wouldn't be having a discussion about Omicron."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Buddhist Monk and Peace Activist Thích Nhất Hạnh Dead at 95

"He inspired so many good people to dedicate themselves to working for a more just and compassionate world."

Jessica Corbett ·


Draft Order Shows Trump Considered Using Military to Seize Voting Machines

"This was part of the records that Trump was fighting to keep from the January 6th committee," one government watchdog noted.

Brett Wilkins ·


Groups Warn US Lawmakers Against Fueling 'New Cold War' With China

A policy of hostility toward Beijing, says a global justice advocate, has "become a convenient excuse for pushing a corporate, militarist agenda."

Jessica Corbett ·


Democracy 'On the Line' Says Bowman After Protest Arrest

"I will not stand by and I will not stay quiet while the fate of our democracy continues to hang loosely by a thread that the Senate is hellbent on tearing apart."

Julia Conley ·


To 'Hold Her Accountable for What She Did,' Primary Sinema Project Gets Into Gear

"Kyrsten Sinema is unfit to be a United States senator," the project asserts. "Just like the filibuster itself, we need to get rid of her if we want to save our democracy before it's too late."

Brett Wilkins ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo